Tumor characteristics, cone-beam CT angiography techniques, and intra-arterial chemotherapy protocol
| Patient No. | Age, Year/Sex | Tumor Type | Cone-Beam CT Protocols | Intra-arterial Chemotherapy Protocol | ||||
|---|---|---|---|---|---|---|---|---|
| Location of Tip of Catheter | Scanning Delay, s | Injection Flow Rate, mL/s | Volume, mL | Chemotherapy Agent | Dose to Sites of Infusion | |||
| 1 | 64/M | Oral floor carcinoma | lt. occipital artery | 1 | 0.5 | 5.5 | CBDCA | 150 mg to lt. occipital artery |
| lt. facial artery | 1 | 1 | 11 | 50 mg to lt. facial artery | ||||
| lt. lingual artery | 1 | 1 | 11 | 230 mg to lt. lingual artery | ||||
| 2 | 73/M | Upper gingival cancer | lt. maxillary artery | 1 | 1 | 11 | CBDCA | 460 mg to lt. maxillary artery |
| 3 | 85/F | Upper gingival | lt. facial artery | 1 | 1 | 11 | CBDCA | 250 mg to lt. facial artery |
| cancer | lt. buccal artery | 1 | 0.5 | 5.5 | 50 mg to lt. buccal artery | |||
| 4 | 62/M | Parotid carcinoma | lt. facial artery | 1 | 1 | 11 | CDDP | 35 mg to lt. facial artery |
| lt. occipital artery | 1 | 0.5 | 5.5 | 50 mg to lt. occipital artery | ||||
| lt. buccal artery | 1 | 0.5 | 5.5 | 15 mg to lt. buccal artery | ||||
| 5 | 55/M | Lower gingival cancer | lt. buccal artery | 1 | 1 | 11 | CBDCA | 540 mg to lt. buccal artery |
| 6 | 67/M | Maxillary cancer | lt. maxillary artery | 1 | 1 | 11 | CDDP | 15 mg to lt. maxillary artery |
| lt. facial artery | 1 | 1 | 11 | 20 mg to lt. facial artery | ||||
| lt. ascending pharyngeal | 1 | 0.5 | 5.5 | 15 mg to lt. ascending pharyngeal | ||||
| 7 | 45/M | Tongue cancer | rt. ascending pharyngeal | 1 | 0.5 | 5.5 | CDDP | 15 mg to rt. ascending pharyngeal |
| rt. lingual artery | 1 | 1 | 11 | 50 mg to rt. lingual artery | ||||
| 8 | 65/M | Oral floor carcinoma | rt. lingual artery | 1 | 1 | 11 | CBDCA | 450 mg to rt. lingual artery |
| 9 | 65/M | Cervical lymph node metastasis | lt. posterior auricular artery | 1 | 1 | 11 | CBDCA | 80 mg to lt. posterior auricular artery |
| 10 | 73/F | Maxillary cancer | lt. maxillary artery | 1 | 1 | 11 | CDDP | 100 mg to lt. maxillary artery |
| 11 | 57/F | Lower gingival cancer | rt. facial artery | 1 | 1 | 11 | CBDCA | 250 mg to rt. facial artery |
| 12 | 64/M | Maxillary cancer | rt. maxillary artery | 1 | 1 | 11 | CDDP | 10 mg to rt. maxillary artery |
| rt. facial artery | 1 | 1 | 11 | 20 mg to rt. facial artery | ||||
| 13 | 64/M | Lower gingival | rt. lingual artery | 1 | 1 | 11 | CBDCA | 200 mg to rt. lingual artery |
| cancer | rt. facial artery | 1 | 1 | 11 | 200 mg to rt. facial artery | |||
| 14 | 79/F | Buccal cancer | rt. maxillary artery | 1 | 1 | 11 | CBDCA | 150 mg to rt. maxillary artery |
| rt. facial artery | 1 | 1 | 11 | 150 mg to rt. facial artery | ||||
| 15 | 78/F | Buccal cancer | rt. facial artery | 1 | 1 | 11 | CBDCA | 175 mg to rt. facial artery |
| 16 | 65/M | Buccal cancer | rt. maxillary artery | 1 | 1 | 11 | CBDCA | 460 mg to rt. maxillary artery |
| internal maxillary artery* | 1 | 1 | 11 | |||||
| rt. facial artery* | 1 | 1 | 11 | |||||
| 17 | 71/M | Carcinoma of the | lt. occipital artery | 1 | 0.5 | 5.5 | CDDP | 15 mg to lt. occipital artery |
| middle ear | lt. superficial temporal artery | 1 | 1 | 11 | 50 mg to superficial temporal artery | |||
| lt. posterior auricular artery | 1 | 1 | 11 | 20 mg to posterior auricular artery | ||||
| lt. middle meningeal artery | 1 | 1 | 11 | 10 mg to middle meningeal artery | ||||
| 18 | 72/M | Lower gingival | rt. facial artery | 1 | 1 | 11 | CBDCA | 200 mg to rt. facial artery |
| cancer | rt. inferior alveolar artery | 1 | 1 | 11 | 100 mg to rt. inferior alveolar artery | |||
| rt. masseteric artery | 1 | 0.5 | 5.5 | 200 mg to rt. masseteric artery | ||||
| 19 | 67/F | Maxillary cancer | rt. lingual artery | 1 | 1 | 11 | CBDCA | 150 mg to rt. lingual artery |
| rt. facial artery | 1 | 1 | 11 | 150 mg to rt. facial artery | ||||
| 20 | 85/M | Tongue cancer | rt. lingual artery | 1 | 1 | 11 | CBDCA | 200 mg to rt. lingual artery |
| 21 | 57/M | Cervical lymph node metastasis | lt. occipital artery | 1 | 1 | 11 | CBDCA | 500 mg to lt. occipital artery |
| 22 | 67/M | Cervical lymph node metastasis | lt. occipital artery | 1 | 1 | 11 | CBDCA | 500 mg to lt. occipital artery |
| 23 | 51/M | Lower gingival | rt. facial artery | 1 | 1 | 11 | CBDCA | 100 mg to rt. facial artery |
| cancer | rt. maxillary artery | 1 | 1 | 11 | 300 mg to rt. maxillary artery | |||
Note:—F indicates female; M, male; rt., right; lt., left; CDDP, cisplatin; CBDCA, carboplatin.
* Superselective intra-arterial chemotherapy was not performed.